MAGN:NYSEMagnera Corporation Analysis
Data as of 2026-05-19 - not real-time
$10.30
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Magnera’s stock is trading just above a key technical support level, with the short‑term moving average modestly above the longer‑term average, suggesting limited near‑term upside. The RSI sits in the mid‑range, while the MACD histogram remains negative, indicating a bearish momentum bias despite a neutral overall trend and rising volume.
Fundamentally, the company shows a stark valuation gap: its discounted cash‑flow estimate is well above the current market price, implying considerable upside potential. Recent earnings disclosed a solid adjusted EBITDA and free cash flow generation, alongside continued debt reduction and cost‑management initiatives. The firm’s new corporate responsibility commitments signal a strategic focus on sustainable growth, but high leverage, negative profit margins and elevated beta underscore substantial risk.
Fundamentally, the company shows a stark valuation gap: its discounted cash‑flow estimate is well above the current market price, implying considerable upside potential. Recent earnings disclosed a solid adjusted EBITDA and free cash flow generation, alongside continued debt reduction and cost‑management initiatives. The firm’s new corporate responsibility commitments signal a strategic focus on sustainable growth, but high leverage, negative profit margins and elevated beta underscore substantial risk.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price hovering near technical support
- Bearish MACD momentum
- Upcoming earnings release with positive cash flow
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Significant valuation discount to DCF fair value
- Consistent free cash flow and debt reduction
- Cost‑management initiatives improving operating leverage
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Structural demand for specialty non‑woven products
- High leverage and volatile earnings profile
- Strategic focus on corporate responsibility and sustainability
Key Metrics & Analysis
Financial Health
Revenue Growth-3.40%
Profit Margin-3.37%
P/E Ratio6.1
ROE-10.32%
ROA1.98%
Debt/Equity188.55
P/B Ratio0.4
Op. Cash Flow$185.0M
Free Cash Flow$201.0M
Technical Analysis
TrendNeutral
RSI47.1
Support$9.71
Resistance$12.92
MA 20$10.57
MA 50$10.28
MA 200$11.84
MACDBearish
VolumeIncreasing
Fear & Greed Index89.21
Valuation
Fair Value$26.75
Target Price$14.50
Upside/Downside40.78%
GradeUndervalued
TypeValue
Risk Assessment
Beta1.65
Volatility60.09%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.